Andrei Osterman

Title: Andrei Osterman: Innovator in Antibiotic Development

Introduction

Andrei Osterman is a notable inventor based in San Diego, California. He has made significant contributions to the field of antibiotic development, particularly in targeting bacterial pathogens. His innovative approach focuses on addressing the challenges posed by multidrug-resistant bacteria.

Latest Patents

Osterman holds a patent titled "Targeting NAD biosynthesis in bacterial pathogens." This patent addresses the urgent need for new antibiotics that act on previously unexplored targets. The invention centers around nicotinate mononucleotide adenylyltransferase of the NadD family, an essential enzyme in NAD biosynthesis found in most bacteria. The inventors have successfully identified small molecule compounds that inhibit bacterial target enzymes by interacting with a novel inhibitory binding site on the enzyme, while having no effect on functionally equivalent human enzymes. This innovative approach could pave the way for the development of new antibiotics.

Career Highlights

Throughout his career, Andrei Osterman has worked with esteemed institutions such as the University System of Maryland and the Sanford-Burnham Medical Research Institute. His work has been instrumental in advancing research in the field of antibiotic resistance and enzyme inhibition.

Collaborations

Osterman has collaborated with notable colleagues, including Alexander MacKerell and Hong Zhang. These partnerships have contributed to the success of his research and the development of his patented inventions.

Conclusion

Andrei Osterman's work in targeting NAD biosynthesis in bacterial pathogens represents a significant advancement in the search for new antibiotics. His innovative approach and collaborations with leading researchers highlight his commitment to addressing the challenges of antibiotic resistance.